Advisory Notices
- HRC
- Current: Advisory Notices
New Advisory on Prohibition of Use of Non-FDA Approved Medications
Advisory Regarding Equine Dentistry and Chiropractic Treatment - Updated January 2025
New Advisory on Over-The-Counter Equine Supplements and Herbals - Updated March 2024
Advisory Notice Nebulizer Restrictions on Thoroughbred Racehorses
Advisory Notice License Presentation
Advisory Notice Thyroxine Restricted
Advisory Notice Regarding Use of Bupivacaine
Advisory Notice Regarding Use of Products Containing Isoxsuprine
Advisory on Over-the-Counter Equine Supplements and Herbals
IHRC Recommends Caution in Medication Administrations
Advisory Notice Regarding Adjunct Bleeder Medications
Advisory Notice Regarding Usage of Licensed Veterinarians
Advisory Notice Regarding Residency Programs
Advisory Notice Regarding Use of CBD Products
Advisory Notice Regarding Use of Facial Coverings/Masks
Indicted Trainer Policy
Usage of Licensed Veterinarians
Notice Regarding Use of Altrenogest/Regumate
Horsemen Reminder of Rule Regarding Using a Suspended or Excluded Veterinarian
IHRC Recommends Caution in Medication Administrations
Horsemen Reminded to Avoid Products Containing Levamisole and Tetramisole
Levamisole Linked to Paste Used in the Treatment of EPM